Ledger.Open graph →
SEC Form D · filed March 2, 2023

ABVC BIOPHARMA, INC

Offering
$3.7M
Sold
$3.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
FREMONT, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

Hsin-Hui Miao · Fremont, CADirectorTsang Ming Jiang · Fremont, CADirectorFrancis Chen · Fremont, CADirectorJames H. Simmons Iii · New York, NYDirectorNancy De Liban · New York, NYDirectorNorimi Sakamoto · Goshen, NYDirectorChe-Wei Hsu · Fremont, CADirectorShuling Jiang · Fremont, CADirectorYen-Hsin Chou · Goshen, NYDirectorChang-Jen Jiang · Fremont, CADirectorLeeds Chow · Fremont, CAExecEugene Jiang · Goshen, NYDirectorYoshinobu Odaira · Fremont, CADirectorTsang-Shann Jiang · Fremont, CADirectorHoward Doong · Goshen, NYExecDavid Yakobovitch · New York, NYDirectorJustin Ferri · Boston, MADirectorShuling Jiang · Fremont, CADirectorNorimi Sakamoto · Fremont, CADirectorChe-Wei Hsu · Fremont, CADirectorYen-Hsin Chou · Fremont, CADirectorChang-Jen Jiang · Fremont, CADirectorLeeds Chow · Fremont, CAExecEugene Jiang · Fremont, CADirectorYoshinobu Odaira · Fremont, CADirectorTsang-Shann Jiang · Fremont, CADirectorFrancis Chen · San Diego, CADirectorHoward Doong · Fremont, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗